144,445 members

Skip to content. | Skip to navigation

News

NHS set to save record £300 million on the NHS’s highest drug spend

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

NHS set to save record £300 million on the NHS’s highest drug spend

The NHS is set to save a record £300 million after negotiating deals with five manufacturers on low cost versions of the health service’s most costly drug.

The saving, the biggest ever from a single drug negotiation, was unlocked by the introduction of ‘biosimilar’ versions of adalimumab are double previous estimates – and would pay for 11,700 more community nurses or 19,800 more breast cancer treatments for patients.

The deal should mean hospitals pay around a quarter of the more than £400 million each year they currently spend on adalimumab, which is used to treat severe hospital treated conditions such as rheumatoid arthritis, inflammatory bowel disease and psoriasis.